Company Search:
Advanced Search
Sponsored Links
Aegerion Pharmaceuticals Incorporation Company Snapshot
Aegerion Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aegerion Pharmaceuticals Incorporation with three other companies in this sector in the United States: Nektar Therapeutics (2015 sales of $230.78 million of which 100% was Research and Product Sales), Amphastar Pharmaceuticals Inc ($251.52 million of which 89% was Pharmaceutical), and Pacira Pharmaceuticals Inc ($249.00 million of which 100% was Depo Foam Drug Delivery Technology).

Sales Analysis.
  Stock Performance Chart for Aegerion Pharmaceuticals Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (11/25/2016): 1.92
(Figures in U.S. Dollars)
1 Week 1.6%   13 Weeks 4.9%  
4 Weeks 20.0%   52 Weeks -81.6%  
Aegerion Pharmaceuticals Incorporation Key Data:
  Ticker: AEGR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 239,887,000
(Year Ending Jan 2016).
Employees: 318
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.